STAT5A and cancer: As STAT5 has been shown to be involved in the initiation and progression of several cancers, the inhibition of STAT5 activity in the types of cancers discussed above, as well as in STAT3-inactive breast and liver cancers, could prove to have therapeutic benefits for the patients.